Clinical Trials · NCT03796884
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Enrollment
- 150
- Start date
- Oct 2019
- Locations
- 3 sites, United States
- Primary endpoint
- Pharmacodynamics effect on cGMP levels